QCM
ANIP icon

Quantinno Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Quantinno Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
29,089
+13,922
+92% +$1.12M ﹤0.01% 1814
2026
Q1 		$1.17M Buy
15,167
+11,762
+345% +$918K ﹤0.01% 2025
2025
Q4 		$269K Buy
3,405
+340
+11% +$29.4K ﹤0.01% 2896
2025
Q3 		$281K Buy
+3,065
New +$250K ﹤0.01% 2508

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's ANIP Position: Q2 2026 in Review

Quantinno Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 92% in Q2 2026, buying an estimated $1.12M and bringing the position to 29,089 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Quantinno Capital Management first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Quantinno Capital Management held 29,089 shares of ANI Pharmaceuticals worth $2.41M as of Q2 2026.
  • Quantinno Capital Management bought 13,922 ANI Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • ANI Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1814 holding.
  • Quantinno Capital Management first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.